Taube Hodson Stonex Partners’s Amgen AMGN Stock Holding History

Taube Hodson Stonex Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-323,828	Closed	-$49.7M	–	18
2015 Q2	$49.7M	Sell	323,828 -24,856	-7%	-$3.98M	5.39%	9
2015 Q1	$55.7M	Sell	348,684 -11,301	-3%	-$1.78M	6.38%	9
2014 Q4	$57.3M	Sell	359,985 -14,467	-4%	-$2.25M	5.31%	10
2014 Q3	$52.6M	Buy	374,452 +12,242	+3%	+$1.6M	4.51%	12
2014 Q2	$42.9M	Buy	+362,210	New	+$41.9M	3.72%	15
2013 Q3	–	Sell	-460,025	Closed	-$45.4M	–	18
2013 Q2	$45.4M	Buy	+460,025	New	+$47.7M	4.46%	13

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Taube Hodson Stonex Partners's AMGN Position: Q3 2015 in Review

Taube Hodson Stonex Partners sold out of Amgen (AMGN) in Q3 2015, closing a stake of 323,828 shares — an estimated $49.7M sold.

Taube Hodson Stonex Partners first reported a position in AMGN in Q2 2013 and held it in 6 quarters. The position peaked at $57.3M in Q4 2014. 1,382 funds tracked by Wall St. Rank hold AMGN as of Q3 2015.

Taube Hodson Stonex Partners reported no remaining Amgen position as of Q3 2015 after selling out during the quarter.
Taube Hodson Stonex Partners sold 323,828 Amgen shares in Q3 2015, an estimated $49.7M.
Taube Hodson Stonex Partners first reported a position in Amgen in Q2 2013 and held it in 6 quarters.
Taube Hodson Stonex Partners's Amgen position peaked at $57.3M in Q4 2014.
1,382 funds tracked by Wall St. Rank held Amgen as of Q3 2015.

Based on Taube Hodson Stonex Partners's 13F filing for Q3 2015, filed 5 Nov 2015.